By indication / Peptide receptor radionuclide therapy
Peptide receptor radionuclide therapy
2 imaging agents and 32 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [68Ga]Ga-DOTATATE paired with [177Lu]Lu-DOTATATE | Ga-68 | Approved | 26 |
| [64Cu]Cu-sartate paired with [67Cu]Cu-SARTATE | Cu-64 | Clinical research | 1 |
Therapy
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [111In]In-APH070 | In-111 | Preclinical | 1 |
| [177Lu]Lu-DOTA-cyclo-MG1 | Lu-177 | Preclinical | 1 |
| [177Lu]Lu-DOTA-cyclo-MG2 | Lu-177 | Preclinical | 1 |
| [177Lu]Lu-pentetreotide | Lu-177 | Clinical research | |
| [212Pb]Pb-VMT-alpha-NET | Pb-212 | Clinical research |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch